Global Market for Women’s Health Devices to reach $2.4 Billion by 2021
The increasing number of patients seeking treatment for reproductive and women’s health-related disorders largely comes down to a burgeoning awareness of the impact that such disorders can have on a woman’s quality of life. The understanding that a woman’s quality of life can be vastly improved by new technologies coincides with the awareness that a variety of new treatment options, such as global endometrial ablation and uterine artery embolization, are far less invasive than surgery. For women who suffer from abnormal uterine conditions, such as heavy menstrual bleeding and uterine fibroids, these new technologies offer safe and effective alternative treatment options to patients who do not wish to undergo invasive surgery.
Our latest MediPoint: Women’s Health – Global Analysis and Market Forecasts report provides analysis of the women’s health devices space across the 10 major markets of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India, including annualized market data from 2014 and forecast until 2021.
Single User Price: $6,495 – No. of pages: 350